Yahoo! Finance: Top Stories

IBD 50's Axsome Therapeutics Dives On Mixed ADHD Results. Why Analysts Aren't Worried.

Mar 25, 2025 - 18:11
 0
IBD 50's Axsome Therapeutics Dives On Mixed ADHD Results. Why Analysts Aren't Worried.
Read More

Tags:

Previous Article

Serinus Energy receives takeover offer from Xtellus Capital Partners

Next Article

Wall Street Sees Stock Rout Ending, While European Rivals Are Not So Sure

Related Posts

BMW Expects $1.1 Billion Earnings Hit From Tariffs This Year

BMW Expects $1.1 Billion Earnings Hit From Tariffs This...

Mar 15, 2025  0

Kohl's Credit Card review: Supplement your regular Kohl’s Cash earnings with additional savings

Kohl's Credit Card review: Supplement your regular Kohl...

Mar 7, 2025  0

Stocks Are Higher on Light Volume, Fading Volatility

Stocks Are Higher on Light Volume, Fading Volatility

Mar 26, 2025  0